A Pharmacodynamic Study of the P-glycoprotein (Pgp) Antagonist, CBT-1(Registered Trademark), Evaluating Pgp Inhibition in Tumors and Normal Tissues.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel; Tetrandrine
- Indications Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
Most Recent Events
- 19 Jul 2012 Biomarkers information updated
- 03 Feb 2012 Primary endpoint identified as (drug accumulation ratio) as reported by ClinicalTrials.gov.
- 03 Feb 2012 Primary endpoint identified as (drug accumulation ratio) as reported by ClinicalTrials.gov.